Inovalon Holdings, which provides healthcare analytics to payors, providers and pharmas, raised $600 million by offering 22.2 million shares at $27, above the upwardly revised range of $24 to $26. The company originally planned to offer shares at $21 to $24. Inovalon Holdings plans to list on the NASDAQ under the symbol INOV. Inovalon Holdings initially filed confidentially on 10/10/2014. Goldman Sachs, Morgan Stanley, Citi, BofA Merrill Lynch and UBS Investment Bank acted as lead managers on the deal.
